Shanping Shi

671 total citations
18 papers, 494 citations indexed

About

Shanping Shi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shanping Shi has authored 18 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shanping Shi's work include RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Shanping Shi is often cited by papers focused on RNA modifications and cancer (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Shanping Shi collaborates with scholars based in China and United States. Shanping Shi's co-authors include Howard B. Gutstein, Deborah L. Lewis, Ju-Yeon Jo, Daniel T. Babcock, Michael H. Shaw, Michael J. Galko, Xi Yang, Somnath Mukhopadhyay, A­llyn C. Howlett and Sheela G. Bhartur and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and PLoS ONE.

In The Last Decade

Shanping Shi

17 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanping Shi China 10 241 218 183 69 64 18 494
Junko Kasuya United States 14 197 0.8× 360 1.7× 41 0.2× 124 1.8× 33 0.5× 24 659
Gonzalo H. Olivares Chile 11 239 1.0× 630 2.9× 99 0.5× 32 0.5× 8 0.1× 19 889
Stefanie Engert Germany 6 111 0.5× 153 0.7× 29 0.2× 59 0.9× 20 0.3× 7 489
Kanefusa Kato Japan 12 173 0.7× 347 1.6× 26 0.1× 37 0.5× 35 0.5× 20 571
Rebecca C. Meyer United States 9 175 0.7× 307 1.4× 17 0.1× 28 0.4× 19 0.3× 9 547
Lu-Lu Bu China 15 88 0.4× 189 0.9× 17 0.1× 49 0.7× 18 0.3× 18 456
Feng-Ru Tang China 10 156 0.6× 230 1.1× 19 0.1× 130 1.9× 20 0.3× 23 475
N Nakahata Japan 11 119 0.5× 382 1.8× 61 0.3× 21 0.3× 21 0.3× 27 612
Alexandre Bettencourt da Cruz United States 8 258 1.1× 554 2.5× 36 0.2× 25 0.4× 5 0.1× 8 864
Masahito Shimojo Japan 19 227 0.9× 576 2.6× 30 0.2× 147 2.1× 43 0.7× 31 867

Countries citing papers authored by Shanping Shi

Since Specialization
Citations

This map shows the geographic impact of Shanping Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanping Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanping Shi more than expected).

Fields of papers citing papers by Shanping Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanping Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanping Shi. The network helps show where Shanping Shi may publish in the future.

Co-authorship network of co-authors of Shanping Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Shanping Shi. A scholar is included among the top collaborators of Shanping Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanping Shi. Shanping Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shi, Shanping, et al.. (2024). Identification and verification of diagnostic biomarkers for deep infiltrating endometriosis based on machine learning algorithms. Journal of Biological Engineering. 18(1). 70–70. 1 indexed citations
2.
Shi, Shanping, et al.. (2023). Disulfidptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Cancer. Reproductive Sciences. 31(3). 811–822. 5 indexed citations
3.
Shi, Shanping, Xianwu Chen, Dingli Xu, et al.. (2021). A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets. Archives of Biochemistry and Biophysics. 711. 109016–109016. 9 indexed citations
4.
Shi, Shanping, et al.. (2021). Characterization of the immune cell infiltration landscape in bladder cancer to aid immunotherapy. Archives of Biochemistry and Biophysics. 708. 108950–108950. 3 indexed citations
6.
Chen, Jiayi, et al.. (2021). Cytoglobin promotes sensitivity to ferroptosis by regulating p53‐YAP1 axis in colon cancer cells. Journal of Cellular and Molecular Medicine. 25(7). 3300–3311. 65 indexed citations
7.
Shi, Shanping, et al.. (2020). A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer. Frontiers in Genetics. 11. 598743–598743. 5 indexed citations
8.
Shi, Shanping, Xiaoyue Wu, Yibo Wang, et al.. (2020). CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer. Autoimmunity. 53(4). 210–217. 10 indexed citations
9.
Wu, Xiaoyue, Ming Zhao, Jiayi Chen, et al.. (2020). LncRNAs GACAT3 and LINC00152 regulate each other through miR‐103 and are associated with clinicopathological characteristics in colorectal cancer. Journal of Clinical Laboratory Analysis. 34(9). e23378–e23378. 10 indexed citations
10.
Shi, Shanping, et al.. (2020). Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients. Aging. 12(23). 23917–23930. 6 indexed citations
11.
Shi, Shanping, et al.. (2019). A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma. Yonsei Medical Journal. 60(11). 1013–1013. 7 indexed citations
12.
Hu, Haochang, et al.. (2019). The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome. Autoimmunity. 52(5-6). 192–198. 3 indexed citations
13.
Cui, Yan, et al.. (2014). Platelet-Derived Growth Factor Receptor-β Antagonism Restores Morphine Analgesic Potency against Neuropathic Pain. PLoS ONE. 9(5). e97105–e97105. 13 indexed citations
14.
Wang, Yan, et al.. (2012). Blockade of PDGFR-β activation eliminates morphine analgesic tolerance. Nature Medicine. 18(3). 385–387. 50 indexed citations
15.
Babcock, Daniel T., Shanping Shi, Ju-Yeon Jo, et al.. (2011). Hedgehog Signaling Regulates Nociceptive Sensitization. Current Biology. 21(18). 1525–1533. 89 indexed citations
16.
Anavi‐Goffer, Sharon, Dow P. Hurst, Diane L. Lynch, et al.. (2007). Helix 8 Leu in the CB1 Cannabinoid Receptor Contributes to Selective Signal Transduction Mechanisms. Journal of Biological Chemistry. 282(34). 25100–25113. 43 indexed citations
17.
Liu, Yunguang, Kathleen Wallis, Michaela Egertová, et al.. (2007). CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a. Molecular Pharmacology. 72(6). 1557–1566. 107 indexed citations
18.
Hurst, Dow P., Diane L. Lynch, Herbert H. Seltzman, et al.. (2006). Biarylpyrazole Inverse Agonists at the Cannabinoid CB1 Receptor:  Importance of the C-3 Carboxamide Oxygen/Lysine3.28(192) Interaction. Journal of Medicinal Chemistry. 49(20). 5969–5987. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026